SCHEMBL9705584

SCHEMBL9705584

CN(C(=O)c1ccc(N)cc1)c1ccccc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
KMT2A Q03164 3/20 0.40
MAOA P21397 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GPBAR1 Q8TDU6 1/20 0.39
MAPT P10636 2/20 0.39
GAA P10253 1/20 0.39
MAPK1 P28482 1/20 0.39
PHLPP2 Q6ZVD8 1/20 0.38
MEN1 O00255 2/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 1/20 0.38
PKM P14618 1/20 0.38
APEX1 P27695 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NR1H3 Q13133 1/20 0.38
EGFR P00533 1/20 0.38
ERBB2 P04626 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10878726 0.89 KDM4E (0.46) HTTKMT2AMAOAKDM4EGPBAR1
SCHEMBL338581 0.87 HTT (0.39) HTTKMT2AMAOAKDM4EGPBAR1
SCHEMBL10373323 0.85 HTT (0.44) HTTKMT2AMAOAKDM4EGPBAR1
SCHEMBL7372957 0.85 ALDH1A1 (0.47) GPBAR1ALDH1A1NPSR1
SCHEMBL7373632 0.83 GPBAR1 (0.46) HTTMAOAGPBAR1POLBEGFR
SCHEMBL7376325 0.82 HTT (0.41) HTTKMT2AMAOAKDM4EMAPT
SCHEMBL10373882 0.81 SIRT2 (0.43) HTTKMT2AMAOAKDM4EGAA
SCHEMBL7409011 0.81 KMT2A (0.45) HTTKMT2AMAOAKDM4EGPBAR1
SCHEMBL7366943 0.80 GPBAR1 (0.44) GPBAR1NR1H3
SCHEMBL7373570 0.80 HDAC6 (0.43) HTTKMT2AMAOAKDM4EGPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0194529-B1 USE OF 2-(AMINOPHENYL)-BENZIMIDAZOLE DERIVATIVES IN THE PREPARATION OF MEDICAMENTS FOR COMBATING MALIGN AND NON-MALIGN PROLIFERATIVE AS WELL AS AUTO-IMMUNE DISEASES AND IN IMMUNOSUPPRESSION IN TRANSPLANTATIONS GÖDECKE AKTIENGESELLSCHAFT (DE) 1992-09-02 EP disclosed
US-4933368-A FOR ADMINISTERING TO REAT REFRACTORY TUMORS IN MAMMALS GODECKE AKTIENGESELLSCHAFT (DE) 1990-06-12 US disclosed
US-4857662-A N-phenylbenzamide derivatives GODECKE AKTIENGESELLSCHAFT (DE) 1989-08-15 US disclosed
US-4816485-A AUTOIMMUNE DISEASES, ANTIBODY INHIBITORS WARNER-LAMBERT COMPANY (US) 1989-03-28 US disclosed
EP-0194529-A2 Use of 2-(aminophenyl)-benzimidazole derivatives in the preparation of medicaments for combating malign and non-malign proliferative as well as auto-immune diseases and in immunosuppression in transplantations GÖDECKE AKTIENGESELLSCHAFT (DE) 1986-09-17 EP disclosed
EP-0116967-B1 N-PHENYL-BENZAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1986-01-29 EP disclosed
EP-0116967-A1 N-phenyl-benzamide derivatives, process for their preparation and medicines containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-08-29 EP disclosed